Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance?

被引：137

作者：

Li, Naishi ^{[1
,2
]}

Fu, Jingyuan ^{[3
]}

Koonen, Debby P. ^{[1
]}

Kuivenhoven, Jan Albert ^{[1
]}

Snieder, Harold ^{[4
]}

Hofker, Marten H. ^{[1
]}

机构：

[1] Univ Groningen, Univ Med Ctr Groningen, Dept Mol Genet, Groningen, Netherlands

[2] Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Endocrinol,Key Lab Endocrinol,Minist Hlth, Beijing, Peoples R China

[3] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands

[4] Univ Groningen, Dept Epidemiol, Univ Med Ctr Groningen, Genet Epidemiol & Bioinformat Unit, Groningen, Netherlands

来源：

ATHEROSCLEROSIS | 2014年 / 233卷 / 01期

关键词：

HDL-cholesterol; Triglycerides; Insulin resistance; Dyslipidemia; TYPE-2; DIABETES-MELLITUS; LIFE-STYLE INTERVENTION; CORONARY-HEART-DISEASE; HEPATIC LIPASE GENE; LIPOPROTEIN-LIPASE; MENDELIAN RANDOMIZATION; GLUCOSE-METABOLISM; FOLLOW-UP; CHOLESTEROL; SENSITIVITY;

D O I：

10.1016/j.atherosclerosis.2013.12.013

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Insulin resistance often occurs with dyslipidemia as part of the metabolic syndrome and the current dominant paradigm is that insulin resistance leads to dyslipidemia. However, dyslipidemia may also cause insulin resistance; this was postulated 30 years ago, but has never been substantiated. Establishing whether dyslipidemia plays a causal role in the etiology of insulin resistance is important since it could reveal new avenues for combating type 2 diabetes. In this review we summarize recent evidence from epidemiological, genetic and intervention studies to re-address this old hypothesis. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

引用

页码：130 / 138

页数：9

共 84 条

[1]

[Anonymous], CHANGING VIEWS LIVIN

[2]

[Anonymous], DIABETES CARE

[3] The angiopoietin-like protein 3: a hepatokine with expanding role in metabolism [J].

Arca, Marcello ;

Minicocci, Ilenia ;

Maranghi, Marianna .

CURRENT OPINION IN LIPIDOLOGY, 2013, 24 (04) :313-320

[4] Large-Scale Gene-Centric Meta-analysis across 32 Studies Identifies Multiple Lipid Loci [J].

Asselbergs, Folkert W. ;

Guo, Yiran ;

van Iperen, Erik P. A. ;

Sivapalaratnam, Suthesh ;

Tragante, Vinicius ;

Lanktree, Matthew B. ;

Lange, Leslie A. ;

Almoguera, Berta ;

Appelman, Yolande E. ;

Barnard, John ;

Baumert, Jens ;

Beitelshees, Amber L. ;

Bhangale, Tushar R. ;

Chen, Yii-Der Ida ;

Gaunt, Tom R. ;

Gong, Yan ;

Hopewell, Jemma C. ;

Johnson, Toby ;

Kleber, Marcus E. ;

Langaee, Taimour Y. ;

Li, Mingyao ;

Li, Yun R. ;

Liu, Kiang ;

McDonough, Caitrin W. ;

Meijs, Matthijs El. ;

Middelberg, Rita P. S. ;

Musunuru, Kiran ;

Nelson, Christopher P. ;

O'Connell, Jeffery R. ;

Padmanabhan, Sandosh ;

Pankow, James S. ;

Pankratz, Nathan ;

Rafelt, Suzanne ;

Rajagopalan, Ramakrishnan ;

Romaine, Simon P. R. ;

Schork, Nicholas J. ;

Shaffer, Jonathan ;

Shen, Haiqing ;

Smith, Erin N. ;

Tischfield, Sam E. ;

van der Most, Peter J. ;

van Vliet-Ostaptchouk, Jana V. ;

Verweij, Niek ;

Volcik, Kelly A. ;

Zhang, Li ;

Bailey, Kent R. ;

Bailey, Kristian M. ;

Bauer, Florianne ;

Boer, Jolanda M. A. ;

Braund, Peter S. .

AMERICAN JOURNAL OF HUMAN GENETICS, 2012, 91 (05) :823-838

[5] Effects of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus [J].

Bajaj, M. ;

Suraamornkul, S. ;

Hardies, L. J. ;

Glass, L. ;

Musi, N. ;

DeFronzo, R. A. .

DIABETOLOGIA, 2007, 50 (08) :1723-1731

[6] Differing effect of statins on insulin sensitivity in non-diabetics: A systematic review and meta-analysis [J].

Baker, William L. ;

Talati, Ripple ;

White, C. Michael ;

Coleman, Craig I. .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 87 (01) :98-107

[7] Effect of Torcetrapib on Glucose, Insulin, and Hemoglobin A1c in Subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) Trial [J].

Barter, Philip J. ;

Rye, Kerry-Anne ;

Tardif, Jean-Claude ;

Waters, David D. ;

Boekholdt, S. Matthijs ;

Breazna, Andrei ;

Kastelein, John J. P. .

CIRCULATION, 2011, 124 (05) :555-562

[8] Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study [J].

Beysen, C. ;

Murphy, E. J. ;

Deines, K. ;

Chan, M. ;

Tsang, E. ;

Glass, A. ;

Turner, S. M. ;

Protasio, J. ;

Riiff, T. ;

Hellerstein, M. K. .

DIABETOLOGIA, 2012, 55 (02) :432-442

[9] Preferential uptake of dietary fatty acids in adipose tissue and muscle in the postprandial period [J].

Bickerton, Alex S. T. ;

Roberts, Rachel ;

Fielding, Barbara A. ;

Hodson, Leanne ;

Blaak, Ellen E. ;

Wagenmakers, Anton J. M. ;

Gilbert, Marjorie ;

Karpe, Fredrik ;

Frayn, Keith N. .

DIABETES, 2007, 56 (01) :168-176

[10] 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study [J].

Bray, G. A. ;

Chatellier, A. ;

Duncan, C. ;

Greenway, F. L. ;

Levy, E. ;

Ryan, D. H. ;

Polonsky, K. S. ;

Tobian, J. ;

Ehrmann, D. ;

Matulik, M. J. ;

Clark, B. ;

Czech, K. ;

DeSandre, C. ;

Hilbrich, R. ;

McNabb, W. ;

Semenske, A. R. ;

Goldstein, B. J. ;

Smith, K. A. ;

Wildman, W. ;

Pepe, C. ;

Goldberg, R. B. ;

Calles, J. ;

Ojito, J. ;

Castillo-Florez, S. ;

Florez, H. J. ;

Giannella, A. ;

Lara, O. ;

Veciana, B. ;

Haffner, S. M. ;

Montez, M. G. ;

Lorenzo, C. ;

Martinez, A. ;

Hamman, R. F. ;

Testaverde, L. ;

Bouffard, A. ;

Dabelea, D. ;

Jenkins, T. ;

Lenz, D. ;

Perreault, L. ;

Price, D. W. ;

Steinke, S. C. ;

Horton, E. S. ;

Poirier, C. S. ;

Swift, K. ;

Caballero, E. ;

Jackson, S. D. ;

Lambert, L. ;

Lawton, K. E. ;

Ledbury, S. ;

Kahn, S. E. .

LANCET, 2009, 374 (9702) :1677-1686

← 1 2 3 4 5 6 7 8 9 →